JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A3413 FH535

Summary: Wnt/B-catenin inhibitor

≥36.1 mg/mL
B4818 WAY-262611

Summary: β-Catenin agonist

insoluble in EtOH; insoluble in H2O; ≥8.95 mg/mL
B5979 CCT251545

Summary: Orally bioavailable and potent WNT signaling inhibitor

≥42.2 mg/mL
B4687 iCRT 14

Summary: CRT inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.75 mg/mL
B7700 IQ 1

Target: Stem Cell Differentiation|PP2A/Nkd interaction

Summary: Maintains embryonic stem cell (ESC) pluripotency

≥37.5 mg/mL
A3785 Salinomycin

Target: Antibiotic

Summary: Polyether ionophore antibiotic;anti-cancer
A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A1877 XAV-939
1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A8396 CHIR-99021 (CT99021) HCl

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL